0001178913-22-000827.txt : 20220224
0001178913-22-000827.hdr.sgml : 20220224
20220224163037
ACCESSION NUMBER: 0001178913-22-000827
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220222
FILED AS OF DATE: 20220224
DATE AS OF CHANGE: 20220224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dykan Jeff
CENTRAL INDEX KEY: 0001661229
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36612
FILM NUMBER: 22671561
MAIL ADDRESS:
STREET 1: KOCHAV YOKNEAM BUILDING, FLOOR 6
STREET 2: P.O. BOX 161
CITY: YOKNEAM ILIT
STATE: L3
ZIP: 20692
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ReWalk Robotics Ltd.
CENTRAL INDEX KEY: 0001607962
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 HATNUFA ST.
STREET 2: FLOOR 6
CITY: YOKNEAM ILIT
STATE: L3
ZIP: 2069203
BUSINESS PHONE: 97249590123
MAIL ADDRESS:
STREET 1: 3 HATNUFA ST.
STREET 2: FLOOR 6
CITY: YOKNEAM ILIT
STATE: L3
ZIP: 2069203
FORMER COMPANY:
FORMER CONFORMED NAME: Argo Medical Technologies Ltd.
DATE OF NAME CHANGE: 20140513
4
1
zk2227368.xml
X0306
4
2022-02-22
0
0001607962
ReWalk Robotics Ltd.
RWLK
0001661229
Dykan Jeff
C/O REWALK ROBOTICS LTD.
3 HATNUFA ST., P.O. BOX 161
YOKNEAM ILIT
L3
20692203
ISRAEL
1
0
0
0
Ordinary Shares, par value NIS 0.25 per share
2022-02-22
4
F
0
1100
1.10
D
10618
D
Ordinary Shares, par value NIS 0.25 per share
65655
I
By Partnership
Represents Ordinary Shares sold in the open market on February 22, 2022, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain restricted stock units previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan.
Market price per share of ReWalk Robotics Ltd.'s (the "Company's") Ordinary Shares on the transaction date.
Prior to fiscal year 2021, the Reporting Person immediately and automatically assigned all Ordinary Shares underlying equity awards issued to the Reporting Person by the Company to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Ordinary Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Company with the permission of SCP. No Ordinary Shares were assigned to SCP by the Reporting Person after fiscal year 2020. This Form 4 reflects the Reporting Person's corrected direct and indirect beneficial ownership of Ordinary Shares as of the filing date.
Based on information provided by the Reporting Person and SCP. Includes 50,488 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P., a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P., a limited partnership organized in Israel and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that SCP, through certain of its affiliates, has the right to acquire from IIA. The Reporting Person is therefore deemed to beneficially own 65,655 Ordinary Shares of the Company.
/s/ Ori Gon as attorney-in-fact
2022-02-24